In a notable study that a used single-cell transcriptomics atlas from 15 AML patients and 9 healthy individuals, the authors identified Colony Stimulating Factor 1 Receptor (CSF1R) and CD86 as potential safe and effective targets for CAR therapy in AML. The gene discussed is CD86; the disease is acute myeloid leukemia.